Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
Abramson, J.S., Feldman, T., Kroll-Desrosiers, A.R., Muffly, L.S., Winer, E., Flowers, C.R., Lansigan, F., Nabhan, C., Nastoupil, L.J., Nath, R., Goy, A., Castillo, J.J., Jagadeesh, D., Woda, B., Rosen, S.T., Smith, S.M., Evens, A.M.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
de Vos, S., Swinnen, L.J., Wang, D., Reid, E., Fowler, N., Cordero, J., Dunbar, M., Enschede, S.H., Nolan, C., Petrich, A.M., Ross, J.A., Salem, A.H., Verdugo, M., Agarwal, S., Zhou, L., Kozloff, M., Nastoupil, L.J., Flowers, C.R.
Published in Annals of oncology (01.09.2018)
Published in Annals of oncology (01.09.2018)
Get full text
Journal Article
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
Cottereau, A S, Rebaud, L, Trotman, J, Feugier, P, Nastoupil, L J, Bachy, E, Flinn, I W, Haioun, C, Ysebaert, L, Bartlett, N L, Tilly, H, Casasnovas, O, Ricci, R, Portugues, C, Buvat, I, Meignan, M, Morschhauser, F
Published in Annals of oncology (01.01.2024)
Published in Annals of oncology (01.01.2024)
Get full text
Journal Article
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Fowler, Nathan H, Cheah, Chan Yoon, Gascoyne, Randy D, Gribben, John, Neelapu, Sattva S, Ghia, Paolo, Bollard, Catherine, Ansell, Stephen, Curran, Michael, Wilson, Wyndham H, O'Brien, Susan, Grant, Cliona, Little, Richard, Zenz, Thorsten, Nastoupil, Loretta J, Dunleavy, Kieron
Published in Haematologica (Roma) (01.05.2016)
Published in Haematologica (Roma) (01.05.2016)
Get full text
Journal Article
Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study
Chin, C. K., Lim, K. J., Lewis, K., Jain, P., Qing, Y., Feng, L., Cheah, C. Y., Seymour, J. F., Ritchie, D., Burbury, K., Tam, C. S., Fowler, N. H., Fayad, L. E., Westin, J. R., Neelapu, S. S., Hagemeister, F. B., Samaniego, F., Flowers, C. R., Nastoupil, L. J., Dickinson, M. J.
Published in British journal of haematology (01.12.2020)
Published in British journal of haematology (01.12.2020)
Get full text
Journal Article
Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma
Steiner, R. E., Strati, P., Flowers, C. R., Neelapu, S. S., Green, M., Nastoupil, L. J., Hagemeister, F. B., Feng, L., Ahmed, S., Nair, R., Fayad, L., Lee, H. J., Rodriguez, M. A., Westin, J. R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes
Bock, A. M., Mwangi, R., Wang, Y., Khurana, A., Maurer, M. J., Ayers, A., Kahl, B., Martin, P., Cohen, J., Casulo, C., Lossos, I., Farooq, U., Ayyappan, S., Reicks, T., Habermann, T. M., Flowers, C. R., Cerhan, J. R., Nastoupil, L. J., Nowakowski, G. S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) VS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Flinn, I. W., Jacobson, C. A., Nastoupil, L. J., Morschhauser, F., Davies, A., Buske, C., Corradini, P., Lopez‐Guillermo, A., Reshef, R., Parameswaran, V., Sehgal, A., Tees, M., Lui, C., Xue, W., Beygi, S., Grechko, N., Bolsue, P., Giovanetti, A., To, C., Nahas, M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE
Nastoupil, L. J., Kamdar, M., Chavez, J. C., Ghesquieres, H., Ghosh, M., Holmes, H., López‐Guillermo, A., Martínez‐López, J., Novak, U., Ribrag, V., Roddie, C., Waller, E. K., Feldman, T., Rosenthal, A. C., Sauter, C., Bonin, M., Karmali, R., Montheard, S., Previtali, A., Abramson, J.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA
Rebaud, L., Capobianco, N., Spottiswoode, B., Cottereau, A., Trotman, J., Feugier, P., Nastoupil, L. J., Bachy, E., Flinn, I. W., Haioun, C., Ysebaert, L., Bartlett, N. L., Tilly, H., Casasnovas, R., Ricci, R., Portugues, C., Meignan, M., Morschhauser, F., Buvat, I.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
Cheah, C.Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N.H., Romaguera, J.E., Turturro, F., Hagemeister, F.B., Fayad, L.E., Wang, M., Neelapu, S.S., Nastoupil, L.J., Westin, J.R., Rodriguez, M.A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M.A.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
Cheah, C.Y., Chihara, D., Ahmed, M., Davis, R.E., Nastoupil, L.J., Phansalkar, K., Hagemeister, F.B., Fayad, L.E., Westin, J.R., Oki, Y., Fanale, M.A., Romaguera, J.E., Wang, M.L., Lee, H., Turturro, F., Samaniego, F., Rodriguez, M.A., Neelapu, S.S., Fowler, N.H.
Published in Annals of oncology (01.05.2016)
Published in Annals of oncology (01.05.2016)
Get full text
Journal Article
TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Morschhauser, F., Dahiya, S., Palomba, M. L., Garcia‐Sancho, A. M., Ortega, J. L. Reguera, Kuruvilla, J., Jager, U., Cartron, G., Izutsu, K., Dreyling, M., Kahl, B., Ghesquieres, H., Ardeshna, K., Goto, H., Barbui, A. M., Abramson, J. S., Borchmann, P., Fleury, I., Mielke, S., Farazi, T., Fasan, O., Lymp, J., Vedal, M., Nishii, R., Avilion, A., Papuga, J., Nastoupil, L. J.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
P1455: FIRST‐IN‐HUMAN TRIAL OF CB‐010, A CRISPR‐EDITED ALLOGENEIC ANTI‐CD19 CAR ‐T CELL THERAPY WITH A PD‐1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON‐HODGKIN LYMPHOMA (ANTLER STUDY)
Nastoupil, L. J., O'Brien, S., Holmes, H. E., Dsouza, L., Hart, D., Matsuda, E., Satterfield‐Ledbetter, T., Skoble, J., Garner, E., Bryan, M., Kanner, S., Li, E., Thomas, C. T., Essell, J.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY PRIMARY REFRACTORY STATUS
Saverno, K, Savill, KMZ, Feinberg, B, Galvin, J, Pathak, P, Amoloja, T, Epperla, N, Nastoupil, LJ
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Get full text
Journal Article
REAL-WORLD USE OF TAFASITAMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES BY AGE GROUP (> 70 YEARS AND 70 YEARS)
Epperla, N, Nastoupil, LJ, Savill, KMZ, Feinberg, B, Galvin, J, Pathak, P, Amoloja, T, Vukcevic, M, Saverno, K
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Get full text
Journal Article
REAL-WORLD SEQUENTIAL USE OF CD19-DIRECTED THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: TAFASITAMAB PRECEDING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
Epperla, N, Nastoupil, LJ, Feinberg, B, Galvin, J, Pathak, P, Amoloja, T, Gentile, D, Saverno, K
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Published in Hematology, Transfusion and Cell Therapy (01.10.2024)
Get full text
Journal Article
PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)
Fowler, N. H., Dickinson, M., Martinez‐Lopez, J., Kolstad, A., Schuster, S. J., Dreyling, M., Ghosh, M., Harigae, H., Kersten, M. José, Bachy, E., Popplewell, L., Chavez, J. C., Ho, P. J., Butler, J., Kato, K., von Tresckow, B., Ferreri, A. J. M., Simón, J. A. P., Patten, P. E. M., Andreadis, C., Riedell, P. A., McGuirk, J. P., Nastoupil, L. J., Teshima, T., Offner, F., Petzer, A., Viardot, A., Zinzani, P. L., Malladi, R., Zhang, J., Tiwari, R., Bollu, V., Masood, A., Thieblemont, C.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY
Matasar, M., Bartlett, N. L., Sehn, L. H., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., Ku, M., Nastoupil, L. J., Wei, M. C., Yin, S., To, I., Turner, D., Huang, H., Min, J., Penuel, E., Budde, L. E.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
IBRUTINIB PLUS BR OR R‐CHOP IN PREVIOUSLY TREATED PATIENTS WITH FOLLICULAR OR MARGINAL ZONE LYMPHOMA: THE PHASE 3 SELENE STUDY
Nastoupil, L. J., Hess, G., Pavlovsky, M. A., Danielewicz, I., Freeman, J., García‐Sancho, A. M., Glazunova, V., Grigg, A., Hou, J., Janssens, A., Kim, S. J., Masliak, Z., McKay, P., Merli, F., Munakata, W., Nagai, H., Özcan, M., Preis, M., Wang, T., Zhu, J., Rowe, M., Qin, R., Henninger, T., Curtis, M., Caces, D. B., Thieblemont, C., Salles, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article